Science
NFL and UFC athletes try 'game-changing' psychedelic to treat brain injury
As awareness grows around the dangers of head trauma in sports, a small number of professional fighters and football players are turning to a psychedelic called ibogaine for treatment.
Ibogaine, which is derived from a West African shrub, is a Schedule 1 drug in America with no legal medical uses, and experts urge caution because of the need for further studies. But the results, several athletes say, are “game-changing.”
“It saved my life,” said former NFL offensive guard Robert Gallery, who traveled to Mexico in 2023 to try ibogaine.
“I’m not anxious all the time, I’m not depressed,” he continued, “I can go for a run and be thankful that I’m alive, rather than having a thought that I should step in front of a semi-truck coming down the road.”
The psychedelic substance is derived from the iboga plant, and proponents tout its ability to treat addiction, post-traumatic stress disorder and traumatic brain injury, or TBI.
-
Share via
An observational study of 30 special forces veterans by researchers at Stanford University suggests that ibogaine can be highly effective at reducing anxiety, depression and cognitive challenges associated with TBI.
“This is a miraculous thing,” said retired MMA fighter Tait Fletcher, who credits the treatment with freeing him from suicidal ideation.
NFL Hall of Fame quarterback Brett Favre even tried ibogaine to see if it could help his Parkinson’s, a neurodegenerative disease linked to TBI.
Although athletes are just discovering ibogaine, the drug is well known within the veteran community, which experiences high rates of brain injury and PTSD.
In Stanford’s study on the effects of ibogaine on special forces veterans, participants saw average reductions of 88% in PTSD symptoms, 87% in depression symptoms and 81% in anxiety symptoms. They also exhibited improvements in concentration, information processing and memory.
“No other drug has ever been able to alleviate the functional and neuropsychiatric symptoms of traumatic brain injury,” Dr. Nolan Williams, a professor of psychiatry and behavioral sciences, said in a statement on the results. “The results are dramatic, and we intend to study this compound further.”
A capsule containing a therapeutic dose of ibogaine, a psychedelic used to help treat traumatic brain injury, PTSD and addiction. (Magda Stuglik)
A team member at Ambio Life Sciences in Tijuana prepares a dose of the drug. (Magda Stuglik)
To receive federal approval, ibogaine would need to pass through multiple phases of clinical trials at the Food and Drug Administration and be moved by the Drug Enforcement Administration to a less restrictive drug category.
Schedule 1 drugs are considered to have no federally accepted medical use, a high potential for abuse and a lack of accepted safety. They also include psilocybin, MDMA, LSD and marijuana.
States can work faster than the federal government by carving out exemptions for supervised ibogaine therapy programs, similar to what Oregon has done with psilocybin therapy. Many states have also opted to legalize marijuana for medicinal or recreational use.
Study co-author Dr. Ian Kratter said researchers have reported that ibogaine may stimulate brain healing by causing an increase in certain neurotrophic factors.
“These factors signal for enhanced brain cell survival and synaptic plasticity, which is the ability for brain cells to modify the strength of their connections or even form new connections,” said Kratter, a professor of psychiatry and behavioral sciences. “This might facilitate a healing and recovery process after an injury.”
Ambio Life Sciences has administered ibogaine to hundreds of veterans since opening in 2021.
(Magda Stuglik)
Dr. Kevin Bickart, a UCLA neurology professor who specializes in brain injury in athletes, said that the Stanford study is “remarkably promising” and that it is reasonable to believe professional athletes could experience similar results.
“This group [veterans] is a strong analogue for retired professional athletes from high-contact sports like football or hockey who are now dealing with persistent cognitive and emotional difficulties,” he said.
Dr. Ramon Diaz-Arrastia, director of Penn Medicine’s TBI research center, said that ibogaine is “one of the more promising compounds” for treatment of TBI.
However, Bickart, Diaz-Arrastia and the Stanford researchers all emphasized the need for larger, randomized controlled trials demonstrating a strong therapeutic benefit and safety profile prior to the treatment being used in America.
They also highlighted the fact that ibogaine can cause heart problems such as cardiac arrhythmia and needs to be administered under strict medical supervision. In the Stanford study, cardiac monitoring and magnesium were used to mitigate this danger, and researchers reported that no participants experienced adverse cardiac effects.
Gallery heard about ibogaine when listening to a podcast about veterans whose struggles resonated with his own. He was at the end of his rope and willing to try anything to free himself from dark thoughts and the ringing noise inside his head.
“It was kind of a last-ditch hope for me,” he said. “I was just at that place of needing the noise and the thoughts to stop.”
Gallery’s doctor believes he likely developed CTE (chronic traumatic encephalopathy) as a result of repeated brain injuries during his eight seasons in the NFL. CTE, which can only be diagnosed after death, is a severe neurodegenerative disease that can cause dementia, violent mood swings, loss of motor control and depression.
Many famous athletes who committed suicide were later determined to have CTE, including New England Patriots tight end Aaron Hernandez, Hall of Fame linebacker Junior Seau and Chicago Bears safety Dave Duerson.
Former NFL offensive guard Robert Gallery, who played for the Raiders, credits ibogaine therapy with saving his life and relationship with his family.
(Robert Gallery)
Fletcher, the former MMA fighter who is also an actor and stunt artist, heard about ibogaine through his Navy SEAL friends.
He had experienced many concussions during his fighting career, but it was head trauma during a stunt gone wrong in 2019 that pushed him over the edge and into an extremely dark place.
The following morning he woke up in a state of terror. He didn’t know how to pack his bags or get out of the hotel room he had been staying in for the shoot.
Fletcher spent the next year in near-total seclusion, largely unable to leave his house due to light and sound sensitivity. Like Gallery, he tried many conventional and experimental therapies, but nothing compared with the relief that ibogaine brought him in 2023.
“We’re putting Band-Aids on problems through pharmacology,” he said. “This [ibogaine] is a thing that I watched just set people free. Nothing short of that.”
Keith Jardine, a former UFC fighter, was inspired by Fletcher’s story and traveled to Mexico to receive treatment himself. Retired hockey player Ales Hemsky credits ibogaine with helping free him of the substance use and alcohol dependency that he struggled with after his 16-year career in the NHL.
“It’s been seven months now I haven’t had a sip of alcohol,” he said. “It’s life-changing. It really restarts your brain. It gives you a new path.”
Fletcher has seen the darkness brain injury brings to athletes and the light ibogaine provides. He wants both to be part of a bigger conversation in the professional sports world.
Tait Fletcher, stuntman and former MMA fighter, suffered traumatic brain injury as a result of multiple concussive events during his career.
(Paul Mobley)
“I wish that these big organizations were looking into these things differently, because you could elongate careers and elongate lives,” he said. “And ibogaine is certainly a part of that conversation.”
Favre also wants to see more attention brought to speeding up medical trials of new treatments for brain injury and related conditions. After taking ibogaine, his Parkinson’s symptoms disappeared for three days before gradually returning, he said.
“I’m not disappointed by anything. I’m more excited about the opportunity knowing that I could do it again,” he said. “I’m hoping that this [conversation] helps open the door for not just ibogaine or psychedelic drugs, but just medication or treatments in general that can help people.”
Bickart said there is a major gap in effective, approved treatments for the persistent symptoms of brain injury.
“This leaves many, including veterans and potentially former athletes, without reliable solutions for ongoing disability, cognitive difficulties, and psychiatric conditions like PTSD, depression, and anxiety that can stem from head injuries,” he said.
Inspired by his own experience with ibogaine, Gallery co-founded a nonprofit called Athletes for Care to educate athletes with TBI on treatment options and advocate for research into psychedelic-assisted therapies.
“The sports community is not very good about talking about mental health,” he said. “Seeing the veterans take charge and take care of their community, I want to do that for the sports community and for my friends that I know that are out there suffering.”
NFL Hall of Fame quarterback Brett Favre, at left with Ambio’s Trevor Millar, visited the clinic in Mexico to seek treatment for Parkinson’s disease.
(Trevor Millar)
Gallery, Favre, Hemsky, Fletcher and Jardine are among around a dozen retired contact-sports athletes who have received treatment at the Ambio Life Sciences clinic in Tijuana, which is a popular destination for ibogaine therapy.
Since opening in 2021, Ambio reports administering ibogaine to more than 3,000 patients, including 1,000 military veterans.
Diaz-Arrastia, the Penn Medicine professor, said he would not advise that Americans order ibogaine online or travel outside the country for treatment, as it remains unregulated, with limited research. Bickart, the UCLA professor, echoed these concerns, noting that the most critical caution is safety.
“People should be wary of any unregulated treatments, as the purity dosage and presence of contaminants are often unknown,” Bickart said. “The placebo effect can also be very powerful, especially for treatments that require significant effort and cost.”
Ambio, the clinic that Stanford researchers worked with for their observational study on ibogaine, stressed its safety protocols during treatment, including close monitoring of dosage and patients’ cardiac health.
There is growing political and scientific momentum in America for more clinical research of ibogaine.
In June, Texas approved a historic $50-million investment in state funding to support drug development trials for ibogaine, inspired by the results seen by veterans.
Arizona legislators approved $5 million in state funding for a clinical study on ibogaine in March, and California legislators are pushing to fast-track the study of ibogaine and other psychedelics.
“Honestly, I’m amazed to see how much interest there is in ibogaine now,” said Ambio co-founder Jonathan Dickinson. “We’re starting to see things that we would have thought were unimaginable several years ago.”
Science
After rash of overdose deaths, L.A. banned sales of kratom. Some say they lost lifeline for pain and opioid withdrawal
Nearly four months ago, Los Angeles County banned the sale of kratom, as well as 7-OH, the synthetic version of the alkaloid that is its active ingredient. The idea was to put an end to what at the time seemed like a rash of overdose deaths related to the drug.
It’s too soon to tell whether kratom-related deaths have dissipated as a result — or, really, whether there was ever actually an epidemic to begin with. But many L.A. residents had become reliant on kratom as something of a panacea for debilitating pain and opioid withdrawal symptoms, and the new rules have made it harder for them to find what they say has been a lifesaving drug.
Robert Wallace started using kratom a few years ago for his knees. For decades he had been in pain, which he says stems from his days as a physical education teacher for the Glendale Unified School District between 1989 and 1998, when he and his students primarily exercised on asphalt.
In 2004, he had arthroscopic surgery on his right knee, followed by varicose vein surgery on both legs. Over the next couple of decades, he saw pain-management specialists regularly. But the primary outcome was a growing dependence on opioid-based painkillers. “I found myself seeking doctors who would prescribe it,” he said.
He leaned on opioids when he could get them and alcohol when he couldn’t, resulting in a strain on his marriage.
When Wallace was scheduled for his first knee replacement in 2021 (he had his other knee replaced a few years later), his brother recommended he take kratom for the post-surgery pain.
It seemed to work: Wallace said he takes a quarter of a teaspoon of powdered kratom twice a day, and it lets him take charge of managing his pain without prescription painkillers and eases harsh opiate-withdrawal symptoms.
He’s one of many Angelenos frustrated by recent efforts by the county health department to limit access to the drug. “Kratom has impacted my life in only positive ways,” Wallace told The Times.
For now, Wallace is still able to get his kratom powder, called Red Bali, by ordering from a company in Florida.
However, advocates say that the county crackdown on kratom could significantly affect the ability of many Angelenos to access what they say is an affordable, safer alternative to prescription painkillers.
Kratom comes from the leaves of a tree native to Southeast Asia called Mitragyna speciosa. It has been used for hundreds of years to treat chronic pain, coughing and diarrhea as well as to boost energy — in low doses, kratom appears to act as a stimulant, though in higher doses, it can have effects more like opioids.
Though advocates note that kratom has been used in the U.S. for more than 50 years for all sorts of health applications, there is limited research that suggests kratom could have therapeutic value, and there is no scientific consensus.
Then there’s 7-OH, or 7-Hydroxymitragynine, a synthetic alkaloid derived from kratom that has similar effects and has been on the U.S. market for only about three years. However, because of its ability to bind to opioid receptors in the body, it has a higher potential for abuse than kratom.
Public health officials and advocates are divided on kratom. Some say it should be heavily regulated — and 7-OH banned altogether — while others say both should be accessible, as long as there are age limitations and proper labeling, such as with alcohol or cannabis.
In the U.S., kratom and 7-OH can be found in all sorts of forms, including powder, capsules and liquids — though it depends on exactly where you are in the country. Though the Food and Drug Administration has recommended that 7-OH be included as a Schedule 1 controlled substance under the Controlled Substances Act, that hasn’t been made official. And the plant itself remains unscheduled on the federal level.
That has left states, counties and cities to decide how to regulate the substances.
California failed to approve an Assembly bill in 2024 that would have required kratom products to be registered with the state, have labeling and warnings, and be prohibited from being sold to anyone younger than 21.
It would also have banned products containing synthetic versions of kratom alkaloids. The state Legislature is now considering another bill that basically does the same without banning 7-OH — while also limiting the amount of synthetic alkaloids in kratom and 7-OH products sold in the state.
“Until kratom and its pharmacologically active key ingredients mitragynine and 7-OH are approved for use, they will remain classified as adulterants in drugs, dietary supplements and foods,” a California Department of Public Health spokesperson previously told The Times.
On Tuesday, California Gov. Gavin Newsom announced that the state’s efforts to crack down on kratom products has resulted in the removal of more than 3,300 kratom and 7-OH products from retail stores. According to a news release from the governor’s office, there has been a 95% compliance rate from businesses in removing the products.
(Los Angeles Times photo illustration; source photos by Getty Images)
Newsom has equated these actions to the state’s efforts in 2024 to quash the sale of hemp products containing cannabinoids such as THC. Under emergency state regulations two years ago, California banned these specific hemp products and agents with the state Department of Alcoholic Beverage Control seized thousands of products statewide.
Since the beginning of 2026, there have been no reported violations of the ban on sales of such products.
“We’ve shown with illegal hemp products that when the state sets clear expectations and partners with businesses, compliance follows,” Newsom said in a statement. “This effort builds on that model — education first, enforcement where necessary — to protect Californians.”
Despite the state’s actions, the Los Angeles County Board of Supervisors is still considering whether to regulate kratom, or ban it altogether.
The county Public Health Department’s decision to ban the sale of kratom didn’t come out of nowhere. As Maral Farsi, deputy director of the California Department of Public Health, noted during a Feb. 18 state Senate hearing, the agency “identified 362 kratom-related overdose deaths in California between 2019 and 2023, with a steady increase from 38 in 2019 up to 92 in 2023.”
However, some experts say those numbers aren’t as clear-cut as they seem.
For example, a Los Angeles Times investigation found that in a number of recent L.A. County deaths that were initially thought to be caused by kratom or 7-OH, there wasn’t enough evidence to say those drugs alone caused the deaths; it might be the case that the danger is in mixing them with other substances.
Meanwhile, the actual application of this new policy seems to be piecemeal at best.
The county Public Health Department told The Times it conducted 2,696 kratom-related inspections between Nov. 10 and Jan. 27, and found 352 locations selling kratom products. The health department said the majority stopped selling kratom after those inspections; there were nine locations that ignored the warnings, and in those cases, inspectors impounded their kratom products.
But the reality is that people who need kratom will buy it on the black market, drive far enough so they get to where it’s sold legally or, like Wallace, order it online from a different state.
For now, retailers who sell kratom products are simply carrying on until they’re investigated by county health inspectors.
Ari Agalopol, a decorated pianist and piano teacher, saw her performances and classes abruptly come to a halt in 2012 after a car accident resulted in severe spinal and knee injuries.
“I tried my best to do traditional acupuncture, physical therapy and hydrocortisone shots in my spine and everything,” she said. “Finally, after nothing was working, I relegated myself to being a pain-management patient.”
She was prescribed oxycodone, and while on the medication, battled depression, anhedonia and suicidal ideation. She felt as though she were in a fog when taking oxycodone, and when it ran out, ”the pain would rear its ugly head.” Agalopol struggled to get out of bed daily and could manage teaching only five students a week.
Then, looking for alternatives to opioids, she found a Reddit thread in which people were talking up the benefits of kratom.
“I was kind of hesitant at first because there’re so many horror stories about 7-OH, but then I researched and I realized that the natural plant is not the same as 7-OH,” she said.
She went to a local shop, Authentic Kratom in Woodland Hills, and spoke to a sales associate who helped her decide which of the 47 strains of kratom it sold would best suit her needs.
Agalopol currently takes a 75-milligram dose of mitragynine, the primary alkaloid in kratom, when necessary. It has enabled her to get back to where she was before her injury: teaching 40 students a week and performing every weekend.
Agalopol believes the county hasn’t done its homework on kratom. “They’re just taking these actions because of public pressure, and public pressure is happening because of ignorance,” she said.
During the course of reporting this story, Authentic Kratom has shut down its three locations; it’s unclear if the closures are temporary. The owner of the business declined to comment on the matter.
When she heard the news of the recent closures, Agalopol was seething. She told The Times she has enough capsules of kratom for now, but when she runs out, her option will have to be Tylenol and ibuprofen, “which will slowly kill my liver.”
“Prohibition is not a public health strategy,” said Jackie Subeck, executive director of 7-Hope Alliance, a nonprofit that promotes safe and responsible access to 7-OH for consumers, at the Feb. 18 Senate hearing. “[It’s] only going to make things worse, likely resulting in an entirely new health crisis for Californians.”
Science
There were 13 full-service public health clinics in L.A. County. Now there are 6
Because of budget cuts, the Los Angeles County Department of Public Health has ended clinical services at seven of its public health clinic sites.
As of Feb. 27, the county is no longer providing services such as vaccinations, sexually transmitted infection testing and treatment, or tuberculosis diagnosis and specialty TB care at the affected locations, according to county officials and a department fact sheet.
The sites losing clinical services are Antelope Valley in Lancaster; the Center for Community Health (Leavy) in San Pedro, Curtis R. Tucker in Inglewood, Hollywood-Wilshire, Pomona, Dr. Ruth Temple in South Los Angeles, and Torrance. Services will continue to be provided by the six remaining public health clinics, and through nearby community clinics.
The changes are the result of about $50 million in funding losses, according to official county statements.
“That pushed us to make the very difficult decision to end clinical services at seven of our sites,” said Dr. Anish Mahajan, chief deputy director of the L.A. County Department of Public Health.
Mahajan said the department selected clinics with relatively lower patient volumes. Over the last month, he said, the department has sent letters to patients about the changes, and referred them to unaffected county clinics, nearby federally qualified health centers or other community providers. According to Mahajan, for tuberculosis patients, particularly those requiring directly observed therapy, public health nurses will continue visiting patients.
Public health clinics form part of the county’s healthcare safety net, serving low-income residents and those with limited access to care. Officials said that about half of the patients the county currently sees across its clinics are uninsured.
Mahajan noted that the clinics were established decades ago, before the Affordable Care Act expanded Medi-Cal coverage and increased the number of federally qualified health centers. He said that as more residents gained access to primary care, utilization at some county-run clinics declined.
“Now that we have a more sophisticated safety net, people often have another place to go for their full range of care,” he said.
Still, the closures have unsettled providers who work closely with local vulnerable populations.
“I hate to see any services that serve our at-risk and homeless community shut down,” said Mark Hood, chief executive of Union Rescue Mission in downtown Los Angeles. “There’s so much need out there, so it always is going to create hardship for the people that actually need the help the most.”
Union Rescue Mission does not receive government funding for its healthcare services, Hood said. The mission’s clinics are open not only to shelter guests, up to 1,000 people nightly, but also to people living on the streets who walk in seeking care.
Its dental clinic alone sees nearly 9,000 patients a year, Hood said.
“We haven’t seen it yet, but I expect in the coming days and weeks we’ll see more people coming through our doors looking for help,” he said. “They’re going to have to find help somewhere.” Hood said women experiencing homelessness are especially vulnerable when preventive care, including sexual and reproductive health services, becomes harder to access.
County officials said staffing impacts so far have been managed through reassignment rather than layoffs. Roughly 200 to 300 positions across the department have been eliminated amid funding cuts, officials said, though many were vacant. About 120 employees whose positions were affected have been reassigned; according to Mahajan, no one has been laid off.
The clinic closures come amid broader fiscal uncertainty. Mahajan said that due to the Trump administration’s “Big Beautiful Bill,” Los Angeles County could lose $2.4 billion over the next several years. That funding, he said, supports clinics, hospitals and community clinic partners now absorbing patients who previously went to the clinics that closed on Feb. 27.
In response, the L.A. County Board of Supervisors has backed a proposed half-cent sales tax measure that would generate hundreds of millions of dollars annually for healthcare and public health services. Voters are expected to consider the measure in June.
Science
Mobile clinic brings mammograms to women on Skid Row
Sharon Horton stepped through the door of a sky-blue mobile clinic and onto a Skid Row sidewalk. She wore a yellow knit beanie, gold hoop earrings and the relieved grin of a woman who has finally checked a mammogram off her to-do list.
It had been years since her last breast cancer screening procedure. This one, which took place in City of Hope’s Cancer Prevention and Screening mobile clinic, was faster and easier. The staff was kind. The machine that X-rayed her breast was more comfortable than the cold hard contraption she remembered.
Relatively speaking, of course — it was still a mammogram.
“It’s like, OK, let me go already!” Horton, 68, said with a laugh.
The clinic was parked on South San Pedro Street in front of Union Rescue Mission, the nonprofit shelter where Horton resides. Within a week, City of Hope, a cancer research hospital, would share the results with Horton and Dr. Mary Marfisee, the mission’s family medical services director. If the mammogram detected anything of concern, they’d map out a treatment plan from there.
Naureen Sayani, 47, a resident of Union Rescue Mission, left, discusses her medical history with Adriana Galindo, a medical assistant, before getting a mammogram on last week.
(Kayla Bartkowski / Los Angeles Times)
“It’s very important to take care of your health, and you need to get involved in everything that you can to make your life a better life,” said Horton, who is looking forward to a forthcoming move into Section 8 housing.
Horton was one of the first patients of a new women’s health initiative from UCLA’s Homeless Healthcare Collaborative at Union Rescue Mission. Staffed by third-year UCLA Medical School students and led by Marfisee, a UCLA assistant clinical professor of family medicine, the clinic treats mission residents as well as unhoused people living in the surrounding neighborhood.
The new cancer screening project arrives at a time of dire financial pressures on county public health services.
Citing rising costs and a $50-million reduction in federal, state and local grant and contract income, the Los Angeles County Department of Public Health on Feb. 27 ended services at seven of 13 public clinics that provide vaccines, tests and treatment for sexually transmitted diseases and other services to housed and unhoused county residents.
Although Union Rescue Mission’s own funding comes mainly from private sources and is less imperiled by public cuts, the 135-year-old shelter expects the need for its services to rise, Chief Executive Mark Hood said.
Even as unsheltered homelessness declined for the last two years across Los Angeles County, the unsheltered population on Skid Row — long seen as the epicenter of the region’s homelessness crisis — grew 9% in 2024, the most recent year for which census data are available.
For many local women navigating daily concerns over housing, food and personal safety, “their own health is not a priority,” Marfisee said.
Those whose problems have become too serious to ignore face daunting obstacles to care. Marfisee recalled one patient who came to her with a lump in her breast and no identification.
In order to get a mammogram, Marfisee explained, the woman first needed to obtain a birth certificate, and then a state-issued identification card. Then she needed to enroll in Medi-Cal. After that, clinic staff helped her find a primary care physician who could order the imaging test.
Given the barriers to preventative care, homeless women die from breast cancer at nearly twice the rate of securely housed women, a 2019 study found. Marfisee’s own survey of the mission’s female residents found that nearly 90% were not up to date on recommended cancer screenings like mammograms and pap smears, which detect early cervical cancer.
To address this gap, Marfisee — a dogged patient advocate — reached out to City of Hope. The Duarte-based research and treatment center unveiled in March 2024 its first mobile cancer screening clinic, a moving van-sized clinic on wheels that it deploys to food banks and health centers, as well as to companies offering free mammograms as an employee benefit.
“In true Dr. Mary fashion, she saw the vision,” said Jessica Thies, the mobile screening program’s regional nursing director. After working through some logistical hurdles, the mission and City of Hope secured a date for the van’s first visit.
The next challenge was getting the word out to patients. Marfisee and her students walked through the surrounding neighborhood, went cot to cot in the women’s dorm and held two informational sessions in December and January to answer patients’ questions.
At the sessions, the team walked through the basics of who should get a mammogram (women age 40 or older, those with a family history of breast cancer) and the procedure itself. (“Like a tortilla maker?” one woman asked skeptically after hearing a description of the mammography unit.)
The medical students were able to dispel rumors some women had heard: The test doesn’t damage breast tissue, nor do the X-rays increase cancer risk. Others questioned a mammogram’s value: What good was it knowing they had cancer if they couldn’t get follow-up care?
On this latter point, Marfisee is determined not to let patients fall through the cracks.
Thirteen patients received mammograms at the van’s first visit on Wednesday. Within a week, City of Hope will contact patients with their results and send them to Marfisee and her team. She is already mentally mapping the next steps should any patient have a situation that requires a biopsy or further imaging: working with their case manager at the mission, calling in favors, wrangling with any insurance the patient might have.
“It’ll be a good fight,” Marfisee said, as residents in the adjacent cafeteria carried trays of sloppy joes and burgers to their lunch tables. “But we’ll just keep asking for help and get it done.”
-
World7 days agoExclusive: DeepSeek withholds latest AI model from US chipmakers including Nvidia, sources say
-
Massachusetts1 week agoMother and daughter injured in Taunton house explosion
-
Denver, CO7 days ago10 acres charred, 5 injured in Thornton grass fire, evacuation orders lifted
-
Louisiana1 week agoWildfire near Gum Swamp Road in Livingston Parish now under control; more than 200 acres burned
-
Florida4 days agoFlorida man rescued after being stuck in shoulder-deep mud for days
-
Wisconsin3 days agoSetting sail on iceboats across a frozen lake in Wisconsin
-
Maryland4 days agoAM showers Sunday in Maryland
-
Oregon5 days ago2026 OSAA Oregon Wrestling State Championship Results And Brackets – FloWrestling